This inventor holds 1 USPTO granted patent. Top assignee: Bluebird Bio, Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Oliver Negre: Innovator in Gene Therapy
Introduction
Oliver Negre is a prominent inventor based in Orsay, France. He has made significant contributions to the field of gene therapy, focusing on improving methods and compositions for treating hematopoietic system disorders. His innovative work has the potential to impact the lives of many patients suffering from conditions such as thalassemias and anemias.
Latest Patents
Oliver Negre holds a patent for gene therapy methods. The present invention generally provides improved gene therapy vectors, cell-based compositions, and methods of using the same in gene therapy. Furthermore, it offers enhanced gene therapy compositions for expanding hematopoietic cells and related methods for treating diseases, disorders, and conditions of the hematopoietic system.
Career Highlights
Negre is associated with Bluebird Bio, Inc., a company dedicated to developing innovative gene therapies. His work at the company has positioned him as a key figure in advancing gene therapy technologies.
Collaborations
Throughout his career, Oliver has collaborated with notable professionals in the field, including Philippe Louis Leboulch and Emmanuel Payen. These collaborations have further enriched his research and development efforts.
Conclusion
Oliver Negre's contributions to gene therapy exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in treating hematopoietic disorders, showcasing the importance of research and collaboration in the field.